ERBB2 and breast cancer: MiR-3622b-5p has been reported to impact the Her2-positive BC cell line negatively, and miR-5582-5p, via the long noncoding RNA LUCAT1/miR-5582-3p/TCF7L2 axis, was associated with the regulatory mechanisms of BC stemness [46].